Received Jan 9, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
My friend took the new and 2 weeks later had them in his eyes.; This serious case was reported by a consumer via interactive digital media and described the occurrence of ophthalmic herpes zoster in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, 2 weeks after receiving Shingles vaccine, the patient experienced ophthalmic herpes zoster (Verbatim: My friend took the new and 2 weeks later had them in his eyes.) (serious criteria GSK medically significant). The outcome of the ophthalmic herpes zoster was not reported. It was unknown if the reporter considered the ophthalmic herpes zoster to be related to Shingles vaccine. The company considered the ophthalmic herpes zoster to be unrelated to Shingles vaccine. Additional Information: GSK receipt date 06-JAN-2026 This case was reported by a consumer via interactive digital media. The batch number was not provided, and we are unable to contact the reporter. This is 1 of 4 cases reported by same reporter.; Sender's Comments: A case of Ophthalmic herpes zoster, 2 weeks after receiving Shingles vaccine, in a male patient. Based on the available information, a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow up has not been received. US-GSK-US2026AMR001989:Case for one case for mother US-GSK-US2026AMR001996:case for nurse US-GSK-US2026AMR001998:Invalid Case for friends